Full text is available at the source.
Abstract
Limited evidence exists regarding cancer risk associated with non-metformin glucose-lowering medications.
- The relationship between non-metformin glucose-lowering medications and cancer risk is not well understood.
- This gap in knowledge is particularly notable for both obesity-related and obesity-nonrelated cancers.
- Further research may be needed to clarify potential cancer risks linked to these medications.
Simplified